LP-10d

N/A

Report date: 2024/09/20 14:48:10

NME

Base Information

Drug NameLP-10d

Drug Alias NameLP-10d

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionReceptor-interacting serine/threonine-protein kinase 1 inhibitorsMitogen-activated protein kinase kinase kinase kinase 4 inhibitorsAnaplastic lymphoma kinase inhibitors

TargetsReceptor-interacting serine/threonine-protein kinase 1Mitogen-activated protein kinase kinase kinase kinase 4Anaplastic lymphoma kinase

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesChina Pharmaceutical University

China Registration ClassN/A

Develop Information

Active CompaniesChina Pharmaceutical University

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A